Skip to content

Author

Laksh Kumar

We have 3 of 46 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

National trends in heart failure and hyperlipidemia related mortality in the United States, 1999–2024

Cardiovascular disease remains the leading cause of death in the United States, with heart failure (HF) and hyperlipidemia substantially contributing to mortality. This study aimed to examine national trends in HF-related mortality with coexisting hyperlipidemia from 1999 to 2024 and project future mortality patterns t...

B. Ayalew, D. N. Smith, Laksh Kumar et al. · 0 citations
Review Jul 2026

Efficacy and safety of lorundrostat in uncontrolled hypertension: a systematic review, meta-analysis, and meta-regression

Lorundrostat demonstrates significant antihypertensive efficacy and a manageable safety profile in UH patients and larger, long-term trials are warranted to further validate its safety across broader populations and complete its efficacy profile, emphasizing the unknown long-term cardiovascular outcomes of the interven...

Sumet Kumar, Arshia Arif Janjua, Laksh Kumar et al. · 0 citations
Open access Aug 2026

Mapping the national burden of cellulitis and related conditions in the United States, 1999–2024: a retrospective cohort analysis

Cellulitis-related mortality increased significantly over recent decades and exhibits pronounced demographic and geographic disparities, and targeted prevention strategies, improved access to timely care for high-risk populations, and strengthened public health surveillance are needed to reduce this burden.

A. Altamimi, Abdulrahman Mohammed Dahi, Yazeed S. Aljohani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.